Skip to main content

Waystar Holding Corp.

corporate_fare Company Profile

Waystar Holding Corp.

WAY·NASDAQ·Technology·CIK 0001990354

Waystar provides healthcare organizations with mission-critical AI-powered software that simplifies healthcare payments for providers across the continuum of care. The company's modern cloud-based software helps healthcare clients prioritize patient care and optimize their financial performance. Its enterprise-grade platform streamlines the complex processes providers manage to ensure accurate reimbursement and improves the payments experience for providers, patients, and payers. Waystar leverages internally developed AI and proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, enhancing claim and billing accuracy, strengthening data integrity, and reducing labor costs for providers. The software helps providers get paid faster, accurately, and more efficiently, while ensuring patients receive a modern, transparent, and consumer-friendly financial experience. Waystar's purpose-built software platform addresses the challenges of the complex healthcare payment ecosystem, which spans the full patient journey from pre-service patient onboarding through post-service revenue collection. Clients utilize the software to manage pre-encounter workflows like eligibility checks and prior authorization approvals, mid-encounter workflows such as utilization management, coding and documentation accuracy, and back-end activities including co-pay collection, payer claims submission and monitoring, and denied claims appeals.

Waystar Holding Corp. (NASDAQ:WAY) is a publicly traded company in the Technology sector. Wiseek has independently scored 11 items for WAY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 7/10. Across its 11 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for WAY spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • Waystar Posts 16c Q3 EPS as Revenue Climbs 21% to $325.6M
  • Waystar 10-Q: Q3 Revenue $325.6M (+21%), Net Income $31.0M; NRR Slips to 107.6%
  • Waystar Q3 Revenue Up 21% to $325.6M; FY26 Revenue Guidance $1.277B-$1.287B
  • Waystar Q2 Revenue Beats, Raises Full-Year Guidance Across the Board
  • Waystar Reports Strong Q2 Growth, Appoints New CFO, and Initiates Share Buyback

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.1B
Net Income
$112.09M
Diluted EPS
$0.61
Op. Cash Flow
$309.67M
Free Cash Flow
$283.19M
Operating Income
$249.31M
Cash & Equivalents
$61.35M
Total Debt
$1.47B
Debt / Equity
0.38×
Net Margin
10.2%
Shares Outstanding
191.59M sh
Source: 10-K · filed 2026-02-17 · accession 0001990354-26-000011

Short Interest & Short Volume

8.40 days to cover

FINRA reported short interest of 15,002,197 shares in WAY as of the October 30, 2026 settlement, a 3.3% decrease from the prior period — about 8.4 days to cover at its recent average daily volume. On November 20, 2026, 43.6% of WAY volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)15,002,197 shares as of October 30, 2026
Change vs prior period▼ 3.3%
Days to cover8.40 at avg daily volume of 1,786,664
Daily short volume (FINRA facilities)43.6% of 591,727 shares on November 20, 2026
5-day average short volume54.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with W →
$26.52
52-week range · as of 2026-11-02 $17.26 – $38.09
Market cap
$5.1B
Volume
1.5M (0.8× avg)
3-mo avg 2M
Live data · 2026-11-22 01:27 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed WAY - Latest Insights

WAY
Nov 02, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.14
Real-time Price: $26.52 info
Change: -$1.62 (-6%) info
Market Cap: $5.102B info
WAY
Nov 02, 2026, 4:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $28.14
Real-time Price: $26.52 info
Change: -$1.62 (-6%) info
Market Cap: $5.102B info
WAY
Nov 02, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.14
Real-time Price: $26.52 info
Change: -$1.62 (-6%) info
Market Cap: $5.102B info
WAY
Jul 29, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $26.52 info
Change: +$4.02 (+18%) info
Market Cap: $5.102B info
WAY
Jul 29, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.52
Real-time Price: $26.52 info
Change: +$2.00 (+8%) info
Market Cap: $5.102B info
WAY
Jul 29, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.44
Real-time Price: $26.52 info
Change: +$4.08 (+18%) info
Market Cap: $5.102B info
WAY
May 19, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $18.68
Real-time Price: $26.52 info
Change: +$7.84 (+42%) info
Market Cap: $5.102B info
WAY
Apr 17, 2026, 4:32 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $25.87
Real-time Price: $26.52 info
Change: +$0.649296 (+3%) info
Market Cap: $5.102B info
WAY
Mar 05, 2026, 9:21 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $26.96
Real-time Price: $26.52 info
Change: -$0.440 (-2%) info
Market Cap: $5.102B info
WAY
Feb 17, 2026, 6:49 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $22.41
Real-time Price: $26.52 info
Change: +$4.11 (+18%) info
Market Cap: $5.102B info
WAY
Feb 17, 2026, 6:47 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.41
Real-time Price: $26.52 info
Change: +$4.11 (+18%) info
Market Cap: $5.102B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets